Group Title: Genetic Vaccines and Therapy 2009, 7:3
Title: Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice
CITATION PDF VIEWER PAGE IMAGE ZOOMABLE
Full Citation
STANDARD VIEW MARC VIEW
Permanent Link: http://ufdc.ufl.edu/UF00100293/00001
 Material Information
Title: Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice
Series Title: Genetic Vaccines and Therapy 2009, 7:3
Physical Description: Archival
Creator: Pacak CA
Sakai Y
Thattaliyath BD
Mah CS
Byrne BJ
Publication Date: 39848
 Record Information
Bibliographic ID: UF00100293
Volume ID: VID00001
Source Institution: University of Florida
Holding Location: University of Florida
Rights Management: Open Access: http://www.biomedcentral.com/info/about/openaccess/

Downloads

This item has the following downloads:

tissuespecific ( PDF )


Full Text




Genetic Vaccines and Therapy 1-



Correction

Tissue specific promoters improve specificity of AAV9 mediated
transgene expression following intra-vascular gene delivery in
neonatal mice
Christina A Pacakt, Yoshihisa Sakait, Bijoy D Thattaliyath, Cathryn S Mah*
and Barry J Byrne*


Address: Powell Gene Therapy Center, College of Medicine, University of Florida, 1600 SW Archer Road, Gainesville, FL 32610-0266, USA
Email: Christina A Pacak christina.pacak@childrens.harvard.edu; Yoshihisa Sakai ysakai@ufl.edu; Bijoy D Thattaliyath bijoy@ufl.edu;
Cathryn S Mah* cmah@ufl.edu; Barry J Byrne* bbyrne@ufl.edu
* Corresponding authors tEqual contributors


I Central


Published: 4 February 2009
Genetic Vaccines and Therapy 2009, 7:3 doi:10.1 186/1479-0556-7-3


Received: 28 January 2009
Accepted: 4 February 2009


This article is available from: http://www.gvt-journal.com/content/7/l/3
2009 Pacak et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.



Correction
Since publication of our article [1], it has come to our
attention that the alpha-myosin heavy chain promoter
was incorrectly identified as being of human origin. The
correct origin of the promoter was from mouse.

The corrections within the text are as follows:

Under the heading Findings, 5 paragraph, line 3: "human
alpha-myosin heavy chain" should be "murine alpha-
myosin heavy chain."

Under the heading Findings, 8th paragraph, line 1: "The
human a-MHC promoter" should be "The murine a-MHC
promoter"

Figure 1, Figure legend, line 6; "...created by amplifying
human genomic DNA" should be "... created by amplify-
ing mouse genomic DNA."

The authors regret the error and any inconveniences to the
readers. The results and conclusions of this article remain
unchanged.

References
I. Pacak CA, Sakai Y, Thattaliyath BD, Mah CS, Byrne BJ: Tissue spe-
cific promoters improve specificity ofAAV9 mediated trans-
gene expression following intra-vascular gene delivery in
neonatal mice. Genetic Vaccines and Therapy 2008, 6:13.


Page 1 of 1
(page number not for citation purposes)




University of Florida Home Page
© 2004 - 2010 University of Florida George A. Smathers Libraries.
All rights reserved.

Acceptable Use, Copyright, and Disclaimer Statement
Last updated October 10, 2010 - - mvs